Federal Register / Vol. 83, No. 6 / Tuesday, January 9, 2018 / Notices 1035 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than February 2, 

2018. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Independent Bank Corporation, 

Grand Rapids, Michigan; to merge with 

TCSB Bancorp, Inc., Traverse City, 

Michigan, and thereby indirectly 

acquire voting shares of Traverse City 

State Bank, Traverse City, Michigan. 

Board of Governors of the Federal Reserve 

System, January 3, 2018. 

Ann E. Misback, 

Secretary of the Board. 

[FR Doc. 2018–00147 Filed 1–8–18; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Adapting Clinical Guidelines for the 

Digital Age Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) 

announces the Adapting Clinical 

Guidelines for the Digital Age meeting. 

Adapting Clinical Guidelines for the 

Digital Age is an initiative to improve 

patient care and health outcomes by 

working to ensure that clinical 

guidelines are not only evidence-based 

but also are used in practice. Because 

there are multiple roles in developing 

and disseminating clinical guidelines, it 

is important to get a comprehensive 

understanding of the current challenges 

in translating guidelines in order to 

develop a standardized process for the 

future. The meeting will use the Kaizen 

approach to ensure stakeholder 

perspectives and experiences along the 

clinical guideline continuum are 

collected. Kaizen focuses on continuous 

improvement by bringing together 

stakeholders to gather individual 

perspectives and experiences so that 

improvements can be made to a specific 

area of focus in a process. Additional 

information about Kaizen is available at 

the Electronic Clinical Quality 

Improvement Resource Center website 

(https://ecqi.healthit.gov/ecqi/kaizen). 

The scope of the meeting will 

encompass the following: Gathering 

individual perspectives and experiences 

about guideline creation and 

summarizing the evidence; informatics 

framework for guideline translation; 

dissemination modalities and 

communication methods; translation 

and implementation support; and 

evidence. 

DATES: The meeting will be held 

February 5–9, 2018, from 9:00 a.m. to 

5:00 p.m. EST each day. 

ADDRESSES: The meeting will be held at 

the Centers for Disease Control and 

Prevention’s Century Center Campus, 

2500 Century Parkway, Atlanta, GA 

30345. You should be aware that the 

meeting location is in a Federal 

government facility; therefore, Federal 

security measures are applicable. For 

additional information, please see CDC 

Security Guidelines under 

SUPPLEMENTARY INFORMATION. 

Information regarding meeting logistics 

will be available on the ‘‘Adapting 

Clinical Guidelines for the Digital Age’’ 

website (https://wwwdev.cdc.gov/ophss/ 

WhatWeDoACG.html) closer to the date 

of the meeting. 

Meeting Accessibility: This meeting is 

open to the public, limited only by 

space availability. All in-person meeting 

attendees must RSVP to the point-ofcontact in the FOR FURTHER INFORMATION

CONTACT section by January 17, 2018 to 

ensure the required security procedures 

are completed to gain access to CDC 

facilities. Failure to RSVP by the dates 

identified could result in the inability to 

attend the meeting due to the strict 

security regulations on federal facilities. 

Due to space limitations, we are unable 

to honor all requests. Registrants for the 

in-person meeting will be notified by 

email that their registration has been 

confirmed. The intent is to have equal 

representation of individuals to ensure 

that a wide variety of individual 

perspectives and experiences are 

collected. 

Public Comment: The opportunity for 

public comment will be available during 

the full-group portions of the meeting. 

Individuals wishing to make public 

comments must indicate their desire to 

do so in advance by providing their 

name, organizational affiliation, and the 

topic to be addressed with their RSVP. 

Meeting Accessibility: This meeting is 

available to the public via Webcast. Live 

captioning will also be available. The 

Webcast URL will be sent to registrants 

upon receipt of their RSVP. All webcast 

meeting participants must RSVP by 

January 17, 2018 to receive the webcast 

information, which will be emailed to 

them by Maria Michaels 

(maria.michaels@cdc.gov). 

FOR FURTHER INFORMATION CONTACT: 

Maria Michaels, Office of the Director; 

Office of Public Health Scientific 

Services; Centers for Disease Control 

and Prevention, 1600 Clifton Road, MS– 

E–33, Atlanta, GA 30333, phone: (404) 

498–0997, email: maria.michaels@

cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The purpose of the meeting 

is for CDC and stakeholders to help 

obtain a better understanding of how 

potential changes to clinical guideline 

translation might impact clinicians, 

electronic health record vendors, 

professional organizations, clinical 

decision support developers, federal 

partners, public health partners, 

standard developers, and CDC 

programs. 

Proposed discussion topics*: The 

different stages of guideline translation; 

guideline dissemination; guideline 

adoption; how the guideline 


sradovich on DSK3GMQ082PROD with NOTICES